高红细胞分布宽度作为心力衰竭的预后指标.
Sidhartha Gautam Senapati1, Azra Kothawala2, Vibhor Ahluwalia3
1Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, United States. senapati.sidhartha36@gmail.com.
World journal of methodology
|March 11, 2026
概括
高红细胞分布宽度 (RDW) 显著增加心力衰竭 (HF) 患者的死亡风险. 这一发现强调了RDW作为HF预后和风险分层的有价值生物标志物.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 临床生物标志物 临床生物标志物
背景情况:
- 红细胞分布宽度 (RDW) 量化了红细胞大小的变化.
- 较高的RDW与不良的健康结果有关,包括心血管疾病.
研究的目的:
- 评估高红细胞分布宽度 (RDW) 在被诊断为心力衰竭 (HF) 的患者的预后意义.
主要方法:
- 在PubMed,EMBASE和谷歌学者中进行了系统的文献搜索,直到2024年5月.
- 七项包括11,460名心力衰竭患者的研究被纳入了这项元分析.
- 所有原因的死亡率是主要结果,评估异质性和出版偏差.
主要成果:
- 与最低四分位数相比,RDW最高四分位数 (>15.21%) 的患者面临全因死亡风险增加1.84倍.
- 发现了显著的异质性 (I2=93%) 和潜在的出版偏差.
- 敏感性分析证实了这些发现的可靠性.
结论:
- 高RDW是心力衰竭患者不良结果的可靠预测指标.
- RDW 作为一种简单,具有成本效益的生物标志物,用于高频风险分层.
- 需要进一步的研究来探索RDW的潜在机制和治疗影响在HF.
相关概念视频
Cardiomyopathy IV: Restrictive Cardiomyopathy
706
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
706
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
878
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
878
Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Rheumatic Heart Disease IV: Nursing Management
401
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
401
Pathophysiology of Heart Failure
4.3K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
Cardiomyopathy II: Dilated Cardiomyopathy
698
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
698


